期刊文献+

影响NOD/SCID小鼠淋巴瘤^(18)F-FDG PET摄取的免疫因素分析 被引量:3

Analysis of immune factors on uptake of ^(18)F-FDG in lymphoma of NOD/SCID mice
下载PDF
导出
摘要 目的通过比较两种不同类型免疫缺陷动物肿瘤组织的18F-FDG标准摄取值(SUV),初步探讨B、NK细胞免疫与肿瘤组织的相互作用。方法对NOD/SCID小鼠(T、B、NK免疫联合缺陷)12只,BALB/C裸鼠(无T细胞免疫)12只,分别种植淋巴瘤细胞(A20),成瘤后对各组均经尾静脉注射18 F-FDG 8.32~12.02 MBq(225~325μCi),使用Philips小动物PET进行全身动态和静态扫描,观察B细胞免疫和NK细胞自然杀伤免疫对肿瘤组织摄取18 F-FDG的影响,并分析免疫因素在肿瘤摄取18F-FDG中的作用。结果 NOD/SCID小鼠最大SUV(SUVmax)为18.33±3.42,高于BALB/C裸鼠[(9.66±4.15),t=4.981,P<0.01],平均SUV(SUVmean)为11.04±1.40,高于BALB/C裸鼠[(5.47±3.30),t=4.718,P=0.001]。结论不同免疫状态对小鼠淋巴瘤的18F-FDG摄取水平存在影响。 Objective To explore the interactions between the B, NK cell-mediated immunity and tumor tissue by comparing the standardized uptake value (SUV) of ^18F-FDG uptake of tumor tissue with two different types of immune deficient mice. Methods Twelve NOD/SCID mice (T, B, NK combined immune deficiency) and 12 BALB/C nude mice (no T-cell immunity) were planted lymphoma cells (A20). After the formation of the tumors, all mice were injected with ^18F-FDG 8.32-12.02 MBq (225-325μCi). Whole body dynamic and static scan was performed on Philips Micro-PET to observe the impact of B cells and NK cells on the uptake of 18 F-FDG in lymphoma. And the role of immune factors in the tumor uptake of 18F-FDG was analyzed. Results NOD/SCID mice's maximal SUV (SUVmax) was higher (18.33±3.42) than BALB/C nude mice (9.66 ±4.15, t= 4. 981, P〈0.01), while their mean SUV (SUV ) was also higher (11.04± 1.40) than that of nude mice (5.47±3.30, t=4. 718, P=0.01). Conclusion Different immune statuses of mice affect the level of lymphoma uptake of 18 F-FDG.
出处 《中国医学影像技术》 CSCD 北大核心 2012年第6期1027-1030,共4页 Chinese Journal of Medical Imaging Technology
基金 国家重点基础研究发展计划(973计划)项目(2006CB705705) 国家自然科学基金(39870241 81071183 30270410)
关键词 淋巴瘤 正电子发射型体层摄影术 体层摄影术 X线计算机 18F氟脱氧葡萄糖 免疫学因素 Lymphoma Pozitron-emission tomography Tomography, X-ray computed Fluorodeoxyglucose F18 Immunologic factors
  • 相关文献

参考文献3

二级参考文献53

  • 1Wang J,Sun NC,Nozama Y,et al.Histological and immunohisto-chemical characterization of extranodal diffuse large-cell lymphoma as with prominent spindle cell features.Histopathology,2001,39(5):476-481.
  • 2Kim SJ,Kim BS,Choi CW,et al.Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma,nasal type.Annals of Oncology,2007,18:1382-1387.
  • 3Szczuraszek K,Mazur G,Jelen M,et al.Prognostic Significance of Ki-67 Antigen Expression in Non-Hodgkin's Lymphomas.Anticancer Research,2008,28:1113-1118.
  • 4Kabickova E,Sumerauer D,Cumlivska E,et al.Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease.Eur J Nucl Med Mol Imaging,2006,33:1025-1031.
  • 5Christian la Fougère,Walter Hundt,Nicole Br?ckel,et a1.Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma[J].Eur J Nucl Med Mol Imaging,2006,33:1417-1425.
  • 6Lapela M,Leskinen S,Minn HRI,et al.Increased Glucose Metabolism in Untreated Non-Hodgkin's Lymphoma:A Study With Positron Emission Tomography and Fluorine-18-Fluorodeoxyglucose.Blood,1995,86(9):3522-2527.
  • 7Sachs S,Bilfinger TV,Komaraff E,Increased Standardized Uptake Value in the Primary Lesion Predicts Nodal or Distant Metastases at presentation in Lung Cancer.Clinical Lung Cancer,2005,6(5):310-313.
  • 8Patruno R,Zizzo N,Zito AF et al.Microvascular density and endothelial area correlate with Ki-67 proliferative rate in the canine non-Hodgkin's lymphoma spontaneous model.Leukemia Lymphoma,2006,47:1138-1143.
  • 9Scholzen T,Gerdes J.The Ki-67 protein:from the known and the unknown.J Cell Physiol,2000,182:311-322.
  • 10Broyde A,Boycov O,Strenov Y,et al.Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.American Journal of Hematology,2009,84:338-343.

共引文献22

同被引文献21

  • 1朱鲜阳,韩秀敏,崔春生,盛晓棠,张端珍,侯传举,邓东安,张玉威.经导管射频打孔并球囊扩张治疗婴儿室间隔完整的肺动脉瓣闭锁[J].中华儿科杂志,2007,45(3):194-198. 被引量:18
  • 2Matthews R A. Medical progress depends on animal models-Doesn't it[J]. JR Soc Med, 2008,101(2): 95-98.
  • 3Malcolm J L. Mouse Models in Gastroenterology Research[J]. Gastroenterology, 2012,143(6): 1414-1412.
  • 4Bobewes R, Rimmelzwaan G F, Osterhaus A D. Animal models for the preclinical evaluation of candidate influenza vaccines[J]. Expert Rev, Vaccines, 2010, 9(1): 59-72.
  • 5Casebolt D B.Facilities for dogs, swine, sheep, goats and miscellaneous species[M]. Planning and designing research animal facilities, 2009.
  • 6Steam T M, Cario C L, Savage H S, et al. Early gene expression differences in inbred mouse strains with susceptibility to pulmonary adenomas[J]. Exp Mol Pathol, 2012, 93(3): 455-461.
  • 7Fricker-Gates R A, Gates M A. Stem cell-derived dopamine neurons for brain repair in Parkinson's disease[J]. Regenerative Medicine, 2010,5(2): 267-278.
  • 8Natasa D, Vedad D, Cao C H, et al. Caffeine increase mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells[J]. Neuropharmacology, 2012, 63 (8): 1368-1379.
  • 9Atticus H H, John F B, Halima K. Pre-clinical models of human cerebral small vessel disease: Utility for clinical application[J]. Journal of Neurological Sciences, 2012, 322(1-2): 237-240.
  • 10Faith J J, Rey F E, O'Donnell D, et al. Creating and characterizing communities of human gut microbes in gnotobiotic mice[J]. ISME J, 2010,4(9): 1094-1098.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部